Itomed

Itopride Hydrochloride, the active ingredient in Itomed, is a prokinetic presented as an oral tablet for oral use. It treats functional dyspepsia, gastroesophageal reflux disease and gastric motility disorders in adults, and is indicated for patients experiencing upper gastrointestinal discomfort.

GNH USA supplies Itomed as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide across Europe and other markets.

Itopride Hydrochloride is used to improve gastrointestinal motility in several functional disorders.

- Functional dyspepsia: alleviates post‑prandial fullness, early satiety and upper abdominal discomfort. - Gastroesophageal reflux disease (GERD): reduces reflux episodes by enhancing esophageal clearance. - Gastric motility disorders: promotes gastric emptying and improves related symptoms.

Itopride Hydrochloride may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea - Headache - Dry mouth - Abdominal cramps - Dizziness - Diarrhea

Serious or Rare Side Effects: - Severe allergic reactions (anaphylaxis, rash, swelling) - Cardiac arrhythmias - Extrapyramidal symptoms - Hepatic injury - Significant hypotension

When prescribing Itopride Hydrochloride, consider the following precautions to ensure safe use.

- Assess renal function: evaluate kidney status before initiating therapy. - Monitor hepatic function: use with caution in patients with liver impairment. - Check for hypersensitivity: discontinue if allergic reactions occur. - Avoid concomitant dopamine antagonists: may reduce prokinetic effect. - Pregnancy and lactation: safety not established; weigh benefits and risks. - Store at room temperature: keep in original container, protect from moisture.

Itopride Hydrochloride can interact with other medicines; notable interactions are grouped by clinical significance.

Major Interactions (Avoid): - Antipsychotics (dopamine D2 antagonists): may counteract prokinetic activity. - Strong CYP3A4 inhibitors (e.g., ketoconazole): can increase plasma concentrations. - Monoamine oxidase inhibitors: risk of hypertensive events.

Moderate Interactions (Monitor Closely): - Anticholinergic agents: may diminish therapeutic effect. - Macrolide antibiotics (e.g., erythromycin): additive prokinetic action may cause excess GI stimulation. - Serotonergic drugs (e.g., SSRIs): monitor for potential serotonin‑related adverse effects.